Abogen signs $7.2 bln Novartis deal for mRNA autoimmune drug

🌐 Investing.com (Cyprus) —
Abogen signs $7.2 bln Novartis deal for mRNA autoimmune drug

AI Summary

Chinese biopharmaceutical company Abogen has signed a deal with Novartis valued at up to $7.2 billion for an mRNA autoimmune drug. The agreement links biotechnology development with a major pharmaceutical licensing transaction.

Markets Deals Health AI & Tech Abogen Novartis mRNA autoimmune disease drug development biopharma deal

Read original source →